EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells

Kornélia Szebényi, András Füredi, Eszter Bajtai, Sai Nagender Sama, Agnes Csiszar, Balázs Gombos, Pál Szabó, Michael Grusch, Gergely Szakács

Drug Resistance Updates · 2023-11 · 71 · 101007

DOI: 10.1016/j.drup.2023.101007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-11. Verfasst von Kornélia Szebényi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, H…. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1, Breast Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 1Breast NeoplasmsHumansAnimalsMiceFemaleLipid PeroxidationPharmaceutical PreparationsATP Binding Cassette Transporter, Subfamily BDoxorubicin

Stichwörter der Autor:innen

Drug-tolerant persisterGenetically engineered mouse model of cancerMultidrug resistanceP-glycoproteinTariquidarTriple-negative breast cancer

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1Pharmaceutical PreparationsATP Binding Cassette Transporter, Subfamily BDoxorubicin

Autor:innen und Institutionen

  • Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary. Electronic address: szebenyi.kornelia@ttk.hu.
  • Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary; Institute of Technical Physics and Materials Science, Centre o…
  • Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary; Doctoral School of Pathological Sciences, Semmelweis Universit…
  • Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
  • Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary; Doctoral School of Molecular Medicine, Semmelweis University, Budapest, Hungary.
  • Centre for Structural Study, Research Centre for Natural Sciences, Budapest, Hungary.

Zitieren

APA

Szebényi, K., Füredi, A., Bajtai, E., Sama, S. N., Csiszar, A., Gombos, B., Szabó, P., Grusch, M., & Szakács, G. (2023). Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells. Drug Resistance Updates, 71, 101007. https://doi.org/10.1016/j.drup.2023.101007

Vancouver

Szebényi K, Füredi A, Bajtai E, Sama SN, Csiszar A, Gombos B, et al. Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells. Drug Resistance Updates. 2023;71:101007. doi:10.1016/j.drup.2023.101007

BibTeX
@article{Szebnyi2023,
  author = {Szebényi, Kornélia and Füredi, András and Bajtai, Eszter and Sama, Sai Nagender and Csiszar, Agnes and Gombos, Balázs and Szabó, Pál and Grusch, Michael and Szakács, Gergely},
  title = {Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells},
  journal = {Drug Resistance Updates},
  year = {2023},
  volume = {71},
  pages = {101007},
  doi = {10.1016/j.drup.2023.101007}
}
Kostenlos starten →